Clearance Summary
BINDAZYME ANTI-TISSUE TRANSGLUTAMINASE IGA EIA received FDA 510(k) clearance under submission number K993612, sponsored by The Binding Site, Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1999-12-21.
- Submission: K993612
- Applicant / Sponsor: The Binding Site, Ltd.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5660
- Decision date: 1999-12-21
Classification & Regulation
This clearance is catalogued under FDA product code MVM and 21 CFR 866.5660, within the Immunology review panel as a Class II device.